CLARUS THERAPEUTICS HOLDINGS, INC.: cashflow_operating
| Value | {"amount": -21935000, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "currency": "USD"} |
|---|---|
| Period | 2021-01-01 – 2021-06-30 |
| Status | current |
| Entity | CLARUS THERAPEUTICS HOLDINGS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T18:16:51.640354+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/b77fa0b3-53f1-4294-9bed-2befbe13945e
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-22-224410 · Open the official SEC filing →Retrieved: 2026-08-19T18:16:51.640354+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001817944/cashflow-operating/2021-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/b77fa0b3-53f1-4294-9bed-2befbe13945e
History
- supersedes {"amount": -410236, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "currency": "USD"} (evidence 0001213900-21-042581)